Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma
- PMID: 2558118
- PMCID: PMC12211580
- DOI: 10.1007/BF00391360
Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma
Abstract
Elevated glutamate concentrations are commonly observed in patients with advanced carcinoma, and glutamate was recently found to inhibit the membrane transport of cystine and to impair the function of macrophages and lymphocytes in vitro. We therefore investigated the possibility that elevated plasma glutamate levels may be quantitatively correlated with reduced lymphocyte reactivity and an impaired host response to the tumor. Here we report the results of a study on patients with bronchial carcinoma, which show that patients with plasma glutamate levels above 120 microM have a lower lymphocyte response to mitogens and a substantially higher death rate than those with glutamate levels below 120 microM. This correlation does not prove a causal role of glutamate, but it confirms predictions from the in vitro laboratory data.
References
-
- Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RGB, Rudman D (1984) Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 87:770–776 - PubMed
-
- De Vries JE, Caviles AP, Bont WS, Mendelsohn J (1979) The role of monocytes in human lymphocyte activation by mitogens. J Immunol 122:1099–1107 - PubMed
-
- Dröge W, Eck H-P, Näher H, Pekar U, Daniel V (1988a) Abnormal amino-acid concentrations in blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe Seyler 369:143–148 - PubMed
-
- Eck H-P, Dröge W (1989) Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe Seyler 370:109–113 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical